DANAHER CORP (DHR) Stock Price, Quote, News and Overview
NYSE:DHR - New York Stock Exchange, Inc. - US2358511028 - Common Stock - Currency: USD
DHR Quote, Performance and Key Statistics
210.23
+2.28 (+1.1%)
The current stock price of DHR is 210.23 USD. In the past month the price decreased by -14.42%. In the past year, price decreased by -17.18%.
DHR Competitors/Peers
Symbol | Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| TMO | THERMO FISHER SCIENTIFIC INC | 24.36 | 203.70B | ||
| A | AGILENT TECHNOLOGIES INC | 25.59 | 38.62B | ||
| IQV | IQVIA HOLDINGS INC | 17.15 | 33.64B | ||
| MTD | METTLER-TOLEDO INTERNATIONAL | 31.26 | 26.91B | ||
| WAT | WATERS CORP | 31.58 | 22.26B | ||
| ICLR | ICON PLC | 14.39 | 16.63B | ||
| WST | WEST PHARMACEUTICAL SERVICES | 31.25 | 15.27B | ||
| ILMN | ILLUMINA INC | 38.45 | 14.94B | ||
| RVTY | REVVITY INC | 23.23 | 13.85B | ||
| AVTR | AVANTOR INC | 17.3 | 11.78B | ||
| TEM | TEMPUS AI INC | N/A | 10.72B | ||
| MEDP | MEDPACE HOLDINGS INC | 26.94 | 10.37B |
Related stock screener links
About DHR
Company Profile
Danaher Corp. engages in the design, manufacture, and marketing of professional, medical, industrial, and commercial products and services. The company is headquartered in Washington, Washington Dc and currently employs 61,000 full-time employees. The firm operates through three business segments: Biotechnology, Life Sciences and Diagnostics. The Biotechnology segment includes the bioprocessing and discovery and medical businesses and offers a broad range of equipment, consumables and services that are primarily used by customers to advance and accelerate the research, development, manufacture and delivery of biological medicines. The Life Sciences segment offers a range of instruments, consumables, services and software that are primarily used by customers to study genomics and the basic building blocks of life, including deoxyribonucleic acid (DNA)and ribonucleic acid (RNA), nucleic acid, proteins, metabolites and cells. The Diagnostics segment offers clinical instruments, consumables, software and services that hospitals, physicians’ offices, reference laboratories and other critical care settings use to diagnose disease and make treatment decisions.
Company Info
DANAHER CORP
2200 Pennsylvania Ave NW Ste 800W
WASHINGTON WASHINGTON DC 20037 US
CEO: Rainer M. Blair
Employees: 62000
Company Website: https://www.danaher.com/
Investor Relations: https://investors.danaher.com/
Phone: 12028280850
DANAHER CORP / DHR FAQ
What is the stock price of DANAHER CORP today?
The current stock price of DHR is 210.23 USD. The price increased by 1.1% in the last trading session.
What is the ticker symbol for DANAHER CORP stock?
The exchange symbol of DANAHER CORP is DHR and it is listed on the New York Stock Exchange, Inc. exchange.
On which exchange is DHR stock listed?
DHR stock is listed on the New York Stock Exchange, Inc. exchange.
What is the price forecast or stock price prediction for DANAHER CORP stock?
33 analysts have analysed DHR and the average price target is 286.79 USD. This implies a price increase of 36.42% is expected in the next year compared to the current price of 210.23. Check the DANAHER CORP stock analysts ratings, price target forecast and up-and down grades for more detailed information.
What is DANAHER CORP worth?
DANAHER CORP (DHR) has a market capitalization of 151.18B USD. This makes DHR a Large Cap stock.
How many employees does DANAHER CORP have?
DANAHER CORP (DHR) currently has 62000 employees.
What are the support and resistance levels for DANAHER CORP (DHR) stock?
DANAHER CORP (DHR) has a support level at 206.29 and a resistance level at 210.24. Check the full technical report for a detailed analysis of DHR support and resistance levels.
Is DANAHER CORP (DHR) expected to grow?
The Revenue of DANAHER CORP (DHR) is expected to grow by 1.52% in the next year. Check the estimates tab for more information on the DHR EPS, Sales, EBIT and EBITDA future analyst estimates.
Should I buy DANAHER CORP (DHR) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of DHR, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of DHR, evaluating the profitability, health, valuation and growth aspects
- DANAHER CORP (DHR) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- DANAHER CORP (DHR) Sales and EPS estimates to see what analysts future expectations are.
- DANAHER CORP (DHR) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- DANAHER CORP (DHR) Insider and Institutional Ownership to learn about the owners and their transactions.
- DANAHER CORP (DHR) Stock Chart to make your own analysis
- DANAHER CORP (DHR) Latest news and press-releases to stay up to date.
Does DANAHER CORP (DHR) stock pay dividends?
DANAHER CORP (DHR) has a dividend yield of 0.53%. The yearly dividend amount is currently 1.05. Check the full fundamental report for a detailed analysis of DHR dividend history, reliability and sustainability.
When does DANAHER CORP (DHR) report earnings?
DANAHER CORP (DHR) will report earnings on 2025-04-21, after the market close.
What is the Price/Earnings (PE) ratio of DANAHER CORP (DHR)?
The PE ratio for DANAHER CORP (DHR) is 28.07. This is based on the reported non-GAAP earnings per share of 7.49 and the current share price of 210.23 USD. Check the full fundamental report for a full analysis of the valuation metrics for DHR.
What is the Short Interest ratio of DANAHER CORP (DHR) stock?
The outstanding short interest for DANAHER CORP (DHR) is 0.84% of its float. Check the ownership tab for more information on the DHR short interest.
DHR Technical Analysis
DHR Fundamental Analysis
ChartMill assigns a fundamental rating of 6 / 10 to DHR. Both the health and profitability get an excellent rating, making DHR a very profitable company, without any liquidiy or solvency issues.
DHR Financial Highlights
Over the last trailing twelve months DHR reported a non-GAAP Earnings per Share(EPS) of 7.49. The EPS decreased by -12.09% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 16.33% | ||
| ROA | 5.03% | ||
| ROE | 7.87% | ||
| Debt/Equity | 0.31 |
DHR Ownership and Analysts
ChartMill assigns a Buy % Consensus number of 83% to DHR. The Buy consensus is the average rating of analysts ratings from 33 analysts.
For the next year, analysts expect an EPS growth of 3.18% and a revenue growth 1.52% for DHR